Abstract
Chronic heart failure (CHF) is a common and disabling condition with morbidity and mortality that increase dramatically with advancing age. There are evidences, from both randomized trials and observational studies, that suggest that beta-blockers are effective and well tolerated in elderly as well as in young patients. Nonetheless in clinical practice they are substantially underutilized in elderly patients. The article underlines peculiarities of chronic heart failure treatment with beta-blockers in elderly patients, with a review of the most important published trials.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call